Cite
HARVARD Citation
Seo, J. et al. (2022). Preclinical assessment and randomized Phase I study of CT-P63, a broadly neutralizing antibody targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Emerging microbes & infections. 11 (1), pp. 2315-2325. [Online].